Treatment Registry
TR-0387 Not verifiedRecorded September 2026Last verified October 2026

Brand tirzepatide

Recorded for knownwell · every brand tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Provider website · knownwell

Current availability of this program is not verified.

We earn nothing from this link. It opens knownwell's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesAll 50 states
PrescriberLive visit
CancellationSelf-pay appointments canceled more than 24 hours ahead are refundable. Late cancellation (less than 24 hours) or no-show incurs $50. This is an appointment policy, not a medication refund guarantee.
MembershipNone. “We do not have a membership fee to join our practice.”
Consult fee$299. Self-pay weight-management first visit $299; follow-up visits $149. Prescription costs are separate; insured patient costs vary.

Recorded from knownwell.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — This older record did not identify a medication form. The current pricing page separates Zepbound KwikPen, Zepbound vial, Zepbound pen. We cannot match the earlier record to one of those forms, so this historical record is not currently verified as a distinct offer. See the separately recorded current forms for published medication-reference prices and clinical terms. This does not mean the provider stopped offering care or these medicines. Current form records: TR-1074, TR-1075.

14 further notes concern other knownwell programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0387
Medication category
brand tirzepatide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). knownwell — brand tirzepatide (TR-0387). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0387

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.